EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Nilo Therapeutics is a company that targets a neuronal circuit to treat autoimmune and inflammatory diseases. They aim to regulate the immune system through this approach.
No recent news for this company.
Nilo Therapeutics Raises $101M Series A Led by The Column Group, DCVC Bio and Lux Capital
Nilo Therapeutics Raises $101M Series A to Advance Neural-Circuit Therapies